PSTX Poseida Therapeutics Inc
1,081
$2.87
$0.06
(2.13%)
| Watchers | 1,081 |
| 52-Wk Low | $1.54 |
| 52-Wk High | $4.27 |
| Market Cap | $272.37M |
| Volume | 225,041.00 |
| 52-Wk High | $4.27 |
| 52-Wk Low | $1.54 |
Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual MeetingPR Newswire • 5 days ago
Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting Poseida Highlights Strong Progress on Its Genetic Medicine...
Share to Feed
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology Astellas and Poseida Therapeutics Enter Into Research...
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology Astellas and Poseida Therapeutics Enter Into Research...
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting Poseida Therapeutics Announces Strong Lineup of Presentations at the...
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements...
Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma Poseida Therapeutics...
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, April...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer PR Newswire SAN DIEGO, March 25, 2024 SAN DIEGO...
Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference PR Newswire...